The Claim
GLP-1 receptor agonist and incretin-based therapies combined with lifestyle interventions including diet and physical activity are associated with an average reduction of 10.08 kg in body weight among adults with overweight or obesity.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among adults with overweight or obesity, treatment with GLP-1 receptor agonists or incretin-based therapies along with diet and physical activity is associated with an average weight loss of 10.08 kilograms.
See the scientific wording
GLP-1 receptor agonist and incretin-based therapies, when combined with lifestyle interventions including diet and physical activity, are associated with an average reduction of 10.08 kg in body weight among adults with overweight or obesity, based on a meta-analysis of eight randomized controlled trials, indicating a clinically meaningful benefit for weight management despite high variability across study contexts.
The drug activates brain signals that reduce hunger and slow stomach emptying, causing people to eat less. At the same time, the body switches from burning sugar to burning fat for energy, especially when calories are limited. This shift increases fat breakdown and ketone production, while exercise helps keep muscle from breaking down. The result is a sustained loss of fat mass without a proportional drop in metabolism.
What the research says
1 studyWhen people with extra weight take GLP-1 medications and follow a healthy diet and exercise plan, they typically lose about 10 kilograms — and this study found exactly that. It’s a real and helpful weight loss, even if results vary a bit from person to person.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.